Testicular embryonal carcinoma: A morphologic study of 180 cases highlighting unusual and unemphasized aspects

American Journal of Surgical Pathology

Volumn 38, Issue 5, 2014, Pages 689-697

  Kao, Chia Sui ^a   Ulbright, Thomas M ^a   Young, Robert H ^b   Idrees, Muhammad T ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

differential diagnosis; embryonal carcinoma; morphology; patterns; testis

Indexed keywords

ARTICLE; EMBRYONAL CARCINOMA; HUMAN; MALE; PATHOLOGY; TESTIS TUMOR;

CARCINOMA, EMBRYONAL; HUMANS; MALE; TESTICULAR NEOPLASMS;

EID: 84899486889     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000171     Document Type: Article

References (61)

1. Friedman NB, Moore RA. Tumors of the testis; a report on922 cases. Mil Surg. 1946;99:573-593.
2. Young RH. A brief history of the pathology of the gonads. ModPathol. 2005;18(suppl 2):S3-S17. (Pubitemid 40188614)
3. Marin-Padilla M. Histopathology of the embryonal carcinoma ofthe testes. Embryological evaluation. Arch Pathol. 1968;85:614-622.
4. Alderdice JM, Johnston SR. Embryonal carcinoma of testissimulating seminoma. J Clin Pathol. 1987;40:434-437.
5. Friedman M, Dirienzo AJ. Trophocarcinoma (embryonal carcinoma)of the testis. Factors influencing radiation and surgicaltreatment. Cancer. 1963;16:868-884.
6. Moul JW, Heidenreich A. Prognostic factors in low-stage nonseminomatoustesticular cancer. Oncology. 1996;10:1359-1368. 1374;discussion 1377.
7. Heidenreich A, Sesterhenn IA, Mostofi FK, et al. Prognostic riskfactors that identify patients with clinical stage I nonseminomatousgerm cell tumors at low risk and high risk for metastasis. Cancer.1998;83:1002-1011. (Pubitemid 28401935)
8. Heidenreich A, Sesterhenn IA, Mostofi FK, et al. [Histopathologicand biological prognostic factors of clinical stage I non-seminomatousgerm cell tumors. Implications for risk-adjusted therapy].Urologe A. 1999;38:168-178. (Pubitemid 29155749)
9. Amato RJ, Ro JY, Ayala AG, et al. Risk-adapted treatment forpatients with clinical stage I nonseminomatous germ cell tumor ofthe testis. Urology. 2004;63:144-148; discussion 148-149. (Pubitemid 38147569)
10. Dong P, Liu ZW, Li XD, et al. Risk factors for relapse in patientswith clinical stage I testicular nonseminomatous germ cell tumors.Med Oncol. 2013;30:494.
11. Sogani PC, Fair WR. Surveillance alone in the treatment of clinicalstage I nonseminomatous germ cell tumor of the testis (NSGCT).Semin Urol. 1988;6:53-56.
12. Divrik RT, Akdogan B, Ozen H, et al. Outcomes of surveillanceprotocol of clinical stage I nonseminomatous germ cell tumors-isshift to risk adapted policy justified J Urol. 2006;176:1424-1429;discussion 1429-1430.
13. Fung CY, Kalish LA, Brodsky GL, et al. Stage I nonseminomatousgerm cell testicular tumor: prediction of metastatic potential byprimary histopathology. J Clin Oncol. 1988;6:1467-1473. (Pubitemid 19089036)
14. Dunphy CH, Ayala AG, Swanson DA, et al. Clinical stage Inonseminomatous and mixed germ cell tumors of the testis. Aclinicopathologic study of 93 patients on a surveillance protocolafter orchiectomy alone. Cancer. 1988;62:1202-1206.
15. Jacobsen GK, Rorth M, Osterlind K, et al. Histopathologicalfeatures in stage I non-seminomatous testicular germ cell tumourscorrelated to relapse. Danish Testicular Cancer Study Group.APMIS. 1990;98:377-382. (Pubitemid 20177190)
16. Wishnow KI, Johnson DE, Swanson DA, et al. Identifying patientswith low-risk clinical stage I nonseminomatous testicular tumorswho should be treated by surveillance. Urology. 1989;34:339-343. (Pubitemid 20019697)
17. Freedman LS, Parkinson MC, Jones WG, et al. Histopathology inthe prediction of relapse of patients with stage I testicular teratomatreated by orchidectomy alone. Lancet. 1987;2:294-298.
18. Moul JW, McCarthy WF, Fernandez EB, et al. Percentage ofembryonal carcinoma and of vascular invasion predicts pathologicalstage in clinical stage I nonseminomatous testicular cancer. CancerRes. 1994;54:362-364. (Pubitemid 24053168)
19. Gels ME, Hoekstra HJ, Sleijfer DT, et al. Detection of recurrence inpatients with clinical stage I nonseminomatous testicular germ celltumors and consequences for further follow-up: a single-center 10-year experience. J Clin Oncol. 1995;13:1188-1194.
20. Nicolai N, Pizzocaro G. A surveillance study of clinical stage Inonseminomatous germ cell tumors of the testis: 10-year followup.J Urol. 1995;154:1045-1049.
21. Albers P, Miller GA, Orazi A, et al. Immunohistochemicalassessment of tumor proliferation and volume of embryonalcarcinoma identify patients with clinical stage A nonseminomatoustesticular germ cell tumor at low risk for occult metastasis. Cancer.1995;75:844-850.
22. Albers P, Ulbright TM, Albers J, et al. Tumor proliferative activityis predictive of pathological stage in clinical stage A nonseminomatoustesticular germ cell tumors. J Urol. 1996;155:579-586. (Pubitemid 26023548)
23. Jacobsen GK, Talerman A. Atlas of Germ Cell Tumours. Copenhagen: Munksgaard; 1989.
24. Cardoso de Almeida PC, Scully RE. Diffuse embryoma of the testis.A distinctive form of mixed germ cell tumor. Am J Surg Pathol.1983;7:633-642. (Pubitemid 14230809)
25. Evans RW. Developmental stages of embryo-like bodies in teratomatestis. J Clin Pathol. 1957;10:31-39.
26. Jacobsen GK, Barlebo H, Olsen J, et al. Testicular germ cell tumoursin Denmark 1976-1980. Pathology of 1058 consecutive cases. ActaRadiol Oncol. 1984;23:239-247. (Pubitemid 15072798)
27. Mostofi FK, Sesterhenn IA, Davis CJ Jr. Developments inhistopathology of testicular germ cell tumors. Semin Urol. 1988;6:171-188.
28. Bishop EF, Badve S, Morimiya A, et al. Apoptosis in spermatocyticand usual seminomas: a light microscopic and immunohistochemicalstudy. Mod Pathol. 2007;20:1036-1044. (Pubitemid 47429196)
29. Jacobsen GK. Histogenetic considerations concerning germ celltumours. Morphological and immunohistochemical comparativeinvestigation of the human embryo and testicular germ cell tumours.Virchows Arch A Pathol Anat Histopathol. 1986;408:509-525. (Pubitemid 16154514)
30. Jacobsen GK, von der Maase H, Specht L, et al. Histopathologicalfeatures in stage I seminoma treated with orchiectomy only. J UrolPathol. 1995;3:85-94.
31. Cohen MB, Friend DS, Molnar JJ, et al. Gonadal endodermal sinus(yolk sac) tumor with pure intestinal differentiation: a newhistologic type. Pathol Res Pract. 1987;182:609-616. (Pubitemid 17139645)
32. Clement PB, Young RH, Scully RE. Endometrioid-like variant ofovarian yolk sac tumor. A clinicopathological analysis ofeight cases. Am J Surg Pathol. 1987;11:767-778. (Pubitemid 17143583)
33. Ulbright TM, Roth LM, Brodhecker CA. Yolk sac differentiation ingerm cell tumors. A morphologic study of 50 cases with emphasis onhepatic, enteric, and parietal yolk sac features. Am J Surg Pathol.1986;10:151-164. (Pubitemid 16055153)
34. Kao CS, Idrees MT, Young RH, et al. Solid pattern yolk sac tumor:a morphologic and immunohistochemical study of 52 cases. Am JSurg Pathol. 2012;36:360-367.
35. Javadpour N. The role of biologic tumor markers in testicularcancer. Cancer. 1980;45:1755-1761. (Pubitemid 10153621)
36. Xiao GQ, Chow J, Maniar KP, et al. Micropapillary variant ofembryonal carcinoma: clinicopathological correlation and histochemicalstudy. Int J Surg Pathol. 2013;21:599-602.
37. Cheng L, Zhang S, Eble JN, et al. Molecular genetic evidencesupporting the neoplastic nature of fibrous stroma in testicularteratoma. Mod Pathol. 2012;25:1432-1438.
38. Young RH. Testicular tumors-some new and a few perennialproblems. Arch Pathol Lab Med. 2008;132:548-564. (Pubitemid 351489610)
39. de Peralta-Venturina MN, Ro JY, Ordonez NG, et al. Diffuseembryoma of the testis. An immunohistochemical study of twocases. Am J Clin Pathol. 1994;102:402-405. (Pubitemid 24323330)
40. Young RH, Scully RE. Testicular and paratesticular tumors andtumor-like lesions of ovarian common epithelial and mulleriantypes. A report of four cases and review of the literature. Am J ClinPathol. 1986;86:146-152. (Pubitemid 16072290)
41. Blumberg HM, Hendrix LE. Serous papillary adenocarcinoma ofthe tunica vaginalis of the testis with metastasis. Cancer. 1991;67:1450-1453.
42. Remmele W, Kaiserling E, Zerban U, et al. Serous papillary cystictumor of borderline malignancy with focal carcinoma arising intestis: case report with immunohistochemical and ultrastructuralobservations. Hum Pathol. 1992;23:75-79.
43. Jones MA, Young RH, Srigley JR, et al. Paratesticular serouspapillary carcinoma. A report of six cases. Am J Surg Pathol. 1995;19:1359-1365.
44. Becerra P, Isaac MA, Marquez B, et al. Papillary serous carcinomaof the tunica vaginalis testis. Pathol Res Pract. 2000;196:781-782;discussion 780.
45. Tulunay O, Gogus C, Baltaci S, et al. Clear cell adenocarcinoma ofthe tunica vaginalis of the testis with an adjacent uterus-like tissue.Pathol Int. 2004;54:641-647. (Pubitemid 39149857)
46. Ulbright TM, Young RH. Seminoma with conspicuous signet ringcells: a rare, previously uncharacterized morphologic variant. Am JSurg Pathol. 2008;32:1175-1181.
47. Ulbright TM, Young RH. Seminoma with tubular, microcystic, andrelated patterns: a study of 28 cases of unusual morphologic variantsthat often cause confusion with yolk sac tumor. Am J Surg Pathol.2005;29:500-505. (Pubitemid 40411183)
48. Berney DM, Lee A, Randle SJ, et al. The frequency of intratubularembryonal carcinoma: implications for the pathogenesis of germ celltumours. Histopathology. 2004;45:155-161. (Pubitemid 39120412)
49. Cast JE, Nelson WM, Early AS, et al. Testicular microlithiasis:prevalence and tumor risk in a population referred for scrotalsonography. Am J Roentgenol. 2000;175:1703-1706.
50. Bach AM, Hann LE, Hadar O, et al. Testicular microlithiasis: whatis its association with testicular cancer Radiology. 2001;220:70-75. (Pubitemid 32577962)
51. Rashid HH, Cos LR, Weinberg E, et al. Testicular microlithiasis: areview and its association with testicular cancer. Urol Oncol.2004;22:285-289. (Pubitemid 38993305)
52. Ferreiro JA. Ber-H2 expression in testicular germ cell tumors. HumPathol. 1994;25:522-524. (Pubitemid 24173870)
53. Leroy X, Augusto D, Leteurtre E, et al. CD30 and CD117 (c-kit)used in combination are useful for distinguishing embryonalcarcinoma from seminoma. J Histochem Cytochem. 2002;50:283-285. (Pubitemid 34106767)
54. Looijenga LH, Stoop H, de Leeuw HP, et al. POU5F1 (OCT3/4)identifies cells with pluripotent potential in human germ cell tumors.Cancer Res. 2003;63:2244-2250. (Pubitemid 36538633)
55. Jones TD, Ulbright TM, Eble JN, et al. OCT4 staining in testiculartumors: a sensitive and specific marker for seminoma andembryonal carcinoma. Am J Surg Pathol. 2004;28:935-940. (Pubitemid 38856851)
56. Emerson RE, Ulbright TM. The use of immunohistochemistry inthe differential diagnosis of tumors of the testis and paratestis.Semin Diagn Pathol. 2005;22:33-50. (Pubitemid 43163178)
57. Zynger DL, Dimov ND, Luan C, et al. Glypican 3: a novelmarker in testicular germ cell tumors. Am J Surg Pathol. 2006;30:1570-1575. (Pubitemid 44808793)
58. Ota S, Hishinuma M, Yamauchi N, et al. Oncofetal proteinglypican-3 in testicular germ-cell tumor. Virchows Arch. 2006;449:308-314. (Pubitemid 44367971)
59. Santagata S, Ligon KL, Hornick JL. Embryonic stem cell transcriptionfactor signatures in the diagnosis of primary and metastaticgerm cell tumors. Am J Surg Pathol. 2007;31:836-845. (Pubitemid 47165136)
60. Gopalan A, Dhall D, Olgac S, et al. Testicular mixed germ celltumors: a morphological and immunohistochemical study usingstem cell markers, OCT3/4, SOX2 and GDF3, with emphasis onmorphologically difficult-to-classify areas. Mod Pathol. 2009;22:1066-1074.
61. Nonaka D. Differential expression of SOX2 and SOX17 in testiculargerm cell tumors. Am J Clin Pathol. 2009;131:731-736.